Skip to main content

Professionals Professionals Section

Practices

Education

Awards & Recognition

Expand All >>
Biography Press Room

Jamiel E. Poindexter is a partner in the Tax Department and a member of the Private Investment Funds Group. He focuses on tax and economic issues associated with the formation of and investments in U.S. and non-U.S. venture capital funds, buyout funds, funds-of-funds, secondary funds, and other investment partnerships.

Areas of Concentration

Jamiel advises U.S. and non-U.S. sponsors and institutional investors on all types of fund-related transactions and operations, including:

  • structuring and raising private investment funds;
  • investments by institutional investors in private investment funds;

  • buy-side secondary transactions and sell-side secondary transactions;

  • restructuring of existing funds;

  •  spin outs;

  • succession planning; and

  • portfolio company investments.

Representative Engagements

  • Aberdeen Asset Management: represent fund-of-funds manager in its fund formation and portfolio investments.

  • Alcatel-Lucent Asset Management Corporation: represent corporate pension plan in its alternative investments.

  • Arch Venture Partners: represent U.S.-based venture capital fund manager in its fund formation and investment activities.

  • California State Teachers Retirement System: represent second largest U.S. public pension plan in its alternative investments.

  • General Catalyst Partners: represent U.S.-based venture capital fund manager in its fund formations.

  • HQ Capital: represent global fund-of-funds and secondary funds manager in its fund formations and its primary and secondary investments.

  • Lexington Partners: represent global fund manager in the formation of secondary funds, and in secondary, primary and co-investment transactions.

  • MIT Investment Management Company: represent university endowment in its alternative investments.

  • New Enterprise Associates: represent U.S.-based venture capital fund manager in its fund formations and portfolio investments.

  • NovaQuest Capital Management: Represent pharmaceutical fund manager in its fund formations.

  • W Capital Partners: represent “secondary direct” fund manager in its fund formations and its portfolio transactions.